SSY Group Limited (HKG: 2005)
Hong Kong
· Delayed Price · Currency is HKD
3.570
+0.020 (0.56%)
Dec 31, 2024, 12:08 PM HKT
SSY Group Revenue
SSY Group had revenue of 3.34B HKD in the half year ending June 30, 2024, a decrease of -1.93%. This brings the company's revenue in the last twelve months to 6.47B, up 1.67% year-over-year. In the year 2023, SSY Group had annual revenue of 6.46B with 0.45% growth.
Revenue (ttm)
6.47B
Revenue Growth
+1.67%
P/S Ratio
1.56
Revenue / Employee
1.12M
Employees
5,640
Market Cap
10.09B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 6.46B | 28.98M | 0.45% |
Dec 31, 2022 | 6.43B | 1.08B | 20.11% |
Dec 31, 2021 | 5.36B | 1.10B | 25.72% |
Dec 31, 2020 | 4.26B | -374.78M | -8.08% |
Dec 31, 2019 | 4.64B | 454.89M | 10.88% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 26.04B |
Hansoh Pharmaceutical Group Company | 13.00B |
JD Health International | 58.84B |
WuXi Biologics | 18.39B |
Sinopharm Group | 634.32B |
Innovent Biologics | 8.01B |
Sino Biopharmaceutical | 29.86B |
CSPC Pharmaceutical Group | 33.53B |